Key facts
- RENAISSANCE TECHNOLOGIES LLC filed SCHEDULE 13G for IRONWOOD PHARMACEUTICALS INC Class A common stock, $0.001 par value per share.
- Disclosed ownership: 5.4%.
- Date of event: 15 May 2024.
RENAISSANCE TECHNOLOGIES LLC - 15 May 2024 SCHEDULE 13G Report for IRONWOOD PHARMACEUTICALS INC Class A common stock, $0.001 par value per share
- Filing Manager
- RENAISSANCE TECHNOLOGIES LLC
- Reporting Manager
- Renaissance Technologies LLC
- Shares outstanding
- 160,096,797 shares
- Disclosed Ownership
- 8,597,198 shares
- Ownership
- 5.4%
- Form type
- SCHEDULE 13G
- Filing time
- 13 Nov 2024, 14:41:53 UTC
- Date of event
- 15 May 2024
- SEC
- View on sec.gov
Key filing fact
RENAISSANCE TECHNOLOGIES LLC disclosed 5.4% ownership in IRONWOOD PHARMACEUTICALS INC Class A common stock, $0.001 par value per share on 15 May 2024.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 13 Nov 2024, 14:41.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (2)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Renaissance Technologies LLC | 5.4% | 8,597,198 | 8,597,198 | 0 | Brian Felczak | Chief Financial Officer | |
| Renaissance Technologies Holdings Corporation | 5.4% | 8,597,198 | 8,597,198 | 0 | Brian Felczak | Vice President |
CIK / CUSIP context first